Home infusion is one of the most sought after segments in healthcare services today, and the buyer demand shows it. The broader shift of care out of hospitals and into the home is driving sustained growth for infusion providers, and that trend is expected to continue as payers favor lower cost home settings. Private equity backed platforms and large specialty operators are competing hard to acquire established infusion businesses, and that competition is producing premium multiples for providers with strong clinical teams, clean compliance, and durable referral relationships. Building a home infusion operation from scratch is difficult and slow, so buyers would rather pay up for a running, accredited business than start one. That scarcity works directly in your favor at the negotiating table. A diversified therapy mix and stable payer contracts can push your figure toward the upper end of the range. Many founders built these operations through years of hard clinical and regulatory work and are ready to realize that value. If retirement, reducing your daily role, or capturing today elevated valuations is on your mind, this is an excellent moment to sell.